In March 2025, the company declared new designs for the immediate-to-customer supplying of its Wegovy weight loss drug. The company founded a fresh pharmacy, termed NovoCare, which would charge buyers $499 per month for entry to the drug, under 50 percent the expense of the drug through other ph